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The systemic distribution of Epstein-Barr virus 
(EBV) genomes was studied in paraffin·embedded 
tissues from 12 fatal cases of Post-transplantation 
lymphoproliferative disease (PTW), using an in situ 
hybridization technique employing an alpha-
35S-dCIP-radiolabeled BamHI-W fragment of EBV 
DNA The presence of EBV was documented in vari-
ous PTW-involved organs, The hybridization signal 
for the virus localized predominantly in the abnor-
mal lymphOid cells, but signals also were detected in 
hepatocytes and/or adrenal cortical cells in five 
cases, The distribution of autoradiographic label 
within the lymphoid cells was focal and its intensity 
varied from field to field, suggesting a nonunifor-
mity of the viral genomic load in the infected tissues, 
Recruitment of EBV genome-bearing cells was not 
observed into inflammatory mononuclear infiltrates 
found in organs without histopathologic evidence of 
PTLD. (Am] Pat hoi 1991, 138:1027-1033) 
Epstein-Barr virus (EBV) is a common cause of infectious 
mononucleosis in young individuals. In this disease, initial 
infection is thought to occur through the oropharyngeal 
epithelium, with subsequent transmission of the virus to B 
lymphocytes. The virus induces proliferation and trans-
formation of B cells, which in turn elicits a reactive prolif-
eration of T-suppressor and cytotoxic cells, responsible 
for limiting the B-cell proliferation in normal individuals.1.2 
The clinical manifestations of infectious mononucleosis, 
eg, the tonsillar enlargement, lymphadenopathy, spleno-
megaly, hepatomegaly, and atypical lymphocytosis gen-
erally are explained on the basis of these B- and T-
lymphocyte proliferations. During active disease, EBV 
genomes can be demonstrated in tonsils, lymph nodes, 
and peripheral blood, and persistence of EBV in oropha-
ryngeal secretions and the parotid and lacrimal glands, 
but not lymphoid tissues, has been reported in subjects 
with a previous history of infection.3-8 Cultures of B lym-
phocytes from asymptomatic seropositive individuals ex-
hibit spontaneous transformation to EBV-positive Iympho-
blastoid cell lines, indicating the presence of low levels of 
latent virus presumably immortalized within B cells.9 
When the normal immune mechanisms of an individ-
ual are compromised, as in inherited immunodeficiency, 
X-linked Iymphoproliferative syndrome, systemic chemo-
therapy, and the Acquired Immune Deficiency Syn-
drome, EBV can proliferate unbridled and affect unusual 
locations.1G--17 Although EBV genomes have been dem-
onstrated by Southern blotting, in extralymphoid organs 
in patients with such overwhelming systemic infections, it 
is not known whether in these cases the virus remains 
confined to lymphoid cells. 18,19 To address this issue, we 
used a 35S-labeled EBV DNA probe and in situ hybrid-
ization methodology to examine the precise cellular local-
ization and distribution of EBV genomes in multiple or-
gans from 12 fatal cases of post-transplantation Iym-
phoproliferative disease (PTLD) developing in the setting 
of cyclosporine/prednisone immunosuppression. 
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Materials and Methods 
Cases were selected from the autopsy files at the Chil-
dren's Hospital of Pittsburgh and the Presbyterian Uni-
versity Hospital, Pittsburgh, Pennsylvania. Seven of the 
patients were in the pediatric age group and five were 
adults. Post-transplantation Iymphoproliferative disease 
was confirmed histopathologically in each case using 
previously published criteria.13 Tissues were fixed in 10% 
neutral buffered formalin, embedded in paraffin, cut into 
3-f.l sections, and mounted on slides precoated with 3-
aminopropyltriethoxysilane (Sigma Chemical Co., St. 
Louis, MO) as previously described.4 Sections of verte-
bral bone marrow were decalcified in 5% nitric acid be-
fore paraffin embedding and sectioning. A total of 76 
blocks were selected from 12 cases to ensure adequate 
representation of PTLD lesions in all major organ systems 
(Table 1). Tissues with PTLD-negative inflammatory infil-
trates also were included in the study. 
Clinical and microbiologic data pertaining to these 
cases were obtained from the autopsy protocols and 
hospital records. In situ hybridization was performed, as 
previously reported, on pronase-digested sections using 
a specific probe consisting of the Bam-HI-W fragment of 
EBV DNA, radiolabeled with alpha-35S-dCTp4. Autorad-
iographic exposures used an overlay of Kodak NTB2 
emulsion (Rochester, NY) and lasted 10 to 14 days. After 
development of the emulsion, the sections were counter-
stained with hematoxylin and eosin. The efficacy of the 
procedure was monitored by a parallel run of nasopha-
ryngeal lymphoepithelioma tissue known to contain EBV 
genomes.20 Negative controls included histologically 
normal pediatric liver and adrenal tissue, as well as sim-
ilar tissue with infiltrates of acute lymphocytic leukemia. 
The slides were assessed qualitatively and a clear depo-
sition of grains in excess over the background level (3:1 
or higher, signal-to-noise ratio) was considered to repre-
sent a positive result (Figure 4a, b). The sensitivity of EBV 
detection by the in situ hybridization protocol described 
here previously was estimated to be approximately 12 
copies of EBV genome per cel1.4 
Results 
A summary of our histopathology and in situ hybridization 
findings by individual organs is shown in Table 1. Sec-
tions of the lungs were studied in 10 cases, eight of which 
showed PTLD involvement with EBV genome-bearing 
cells randomly scattered in the PTLD infiltrates. The hy-
bridization signal varied from weak to intense. No labeling 
was observed over bronchial epithelium, smooth muscle, 
endothelium, or alveolar lining cells. Infectious agents 
such as Cytomegalovirus, Candida, Staphylococcus, En-
terobacter, Klebsiella, and Pseudomonas were cultured 
from PTLD tissues in all eight cases. 
The myocardium was examined in nine cases and 
PTLD infiltrates were found in four cases, present in the 
epicardial fat as well as interstitially within the cardiac 
muscle tissue. The EBV labeling was confined to lym-
phoid cells and varied from only scattered cells hybridiz-
ing with the probe to strong autoradiographic signals 
seen in a majority of the cells. No signals were detected 
on myocardial or connective tissue cells. A section taken 
from the aorta in case 8 did not hybridize with the probe. 
The livers showed histologic evidence of PTLD in 
seven of the eight cases. Epstein-Barr virus DNA was 
found in a majority of the infiltrating lymphoid cells, with 
the labeling intensity varying from weak to intense (Figure 
1). Scattered hepatocytes also showed labeling in four 
cases (1, 2, 4, and 7), all of whom were children in the 
age range of 5 to 15 years (Figure 2a, b). No grains 
above background levels were detected in the biliary ep-
ithelium or hepatic reticuloendothelial cells. 
The kidneys manifested histopathologic evidence of 
PTLD in seven of the nine cases. Distribution of PTLD 
within the organs was global with cortex, medulla, as well 
as the peri pelvic soft tissues affected. Infiltrates were 
present in periglomerular, intraglomerular, peritubular, 
and intravascular locations (Figure 3). Epstein-Barr virus 
genomes were found only in the lymphoid cells. The la-
beling intensity varied from case to case and field to field 
as in other organs. 
Examination of the spleen in eight cases showed 
PTLD with expansion of the white pulp and simultaneous 
infiltration of the red pulp. Epstein-Barr virus genomes 
were found in six cases. Lymph node tissues sampled 
from two cases showed diffuse labeling of lymphoid cells 
in areas of PTLD. The thymus examined in one case did 
not show evidence of hybridization with the probe. 
Adrenal glands were evaluated in six cases and PTLD 
infiltrates were found in five cases, involving the cortex, 
the medulla and the periadrenal fat. Hybridization signals 
of variable intensity were found scattered randomly 
throughout these lymphoid infiltrates. Scattered foci of 
adrenal cortical cells with specific labeling were noted in 
two children (cases 4 and 6; Figure 4a, b). 
Decalcified sections of vertebral bone marrow in six 
cases showed a hypercellular marrow with PTLD cells 
accounting for 60% to 90% of the total cell population 
present in five cases. In situ hybridization revealed scat-
tered, weakly labeled EBV-positive lymphoid cells in only 
two cases, but eosinophils and eosinophil precursors 
were labeled intensely in all cases, apparently due to a 
nonspecific disulfide bond formation between 35S_ 
labeled DNA and a protein in the eosinophilic granules. 
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This nonspecific staining of eosinophilic cells also was 
found in control bone marrow tissues, 
The gastrointestinal tract was sampled in five cases 
with histologic evidence of involvement by PTLD. Ep-
steirt-Barr virus genomes were found in seven of eight 
sections of typical lesions in the stomach, small intestine, 
and colon. Labeling was confined to the lymphoid cells, 
which permeated the entire gut wall . The lining epithe-
lium, glands, vascular endothelium, and smooth muscle 
showed no labeling. Lymphocytic infiltrates in the parotid 
gland in one case showed EBV-positive cells. Pancreatic 
tissue studied in three cases showed no histologic evi-
dence of PTLD and no EBV localization. 
Discussion 
Figure 1, Liver lissue wilb PTW lesions show-
ing labeling of bepaJOCYles (upper lefl), and 
portailracl injlltrales (upper rigbl), bUi nol of 
Ihe bile ducl epilhelium (lower left) The level 
of background labeling observed in bepmo-
cy,es and reliculoendolhelial cells from con-
trol livers is also iliustraJed (lower rigbl) He-
maJo_,ylin and eosin Slain, x 1250 
This study confirms the previously reported near-
universal association of EBV with PTLD occurring in solid 
organ transplant recipients. 13 Epsteirt-Barr virus-positive 
lymphoid cells were demonstrated in all patients in a wide 
variety of organs sampled at autopsy. The organ distri-
bution, percentage of cell staining, and the intensity of 
staining in different cells varied considerably from case to 
case. This could reflect differences in the degree of au-
tolysis and fixation conditions; such factors are difficult to 
control for in a retrospective study of archival material. 
However different tumor cells in the same microscopic 
Figure 2. Panoramic view of markedly slea-
lotic liver parenchyma showingfocal aUiora-
diograpbic signals over bepalOC)lles Hema-
loxylin and eosin Slain, x500. 
Epstein-Barr Virus Genomes in Post-transplantation Lymphoproliferation 1031 
Figure 3. EBV-infected ~ymphoid cells in reo 
nal imerslitial PTlJJ irifiltrales. No luhular ep-
ithelium labeling is seen Hemato:..ylin and 
eo;~·n stain, x500 
field, all apparently equally well preserved morphologi-
cally, showed variation in the intensity of their hybridiza-
tion signals. Consequently it is probable that the actual 
viral genomic load in lymphoid cells is not distributed uni-
Figure 4. Nuclei of adrenal cortical cells from case 4 (A) show 
EBV hybridtZalion signals d(,tinctiy stronger than those observed in 
conl1"OitissLte (8). Hematoxylin and eosin stain, X ] 250. 
AJP April 7997, Vol 738, No.4 
formly throughout PTLD lesions. A variable number of 
cells may be in the lytic, rather than the latent, phase of 
the infection.21 Heterogeneity in hybridization with spe-
cific EBV DNA probes also has been observed in virus-
infected celllines,22 and attributed in part to differences in 
the level of mitotic activity between cells.23,24 
It is well known that lymphoid tissues are the major 
target of infection for the EBV, In fully immunocompetent 
subjects, the oropharyngeal mucosa and the parotid and 
lacrimal glands seem to be the only epithelial tissues ca-
pable of harboring EBV.6-8 However it seemed possible 
to us that, under conditions of immunosuppression, a 
wider range of tissues might become susceptible to the 
virus. On careful observation autoradiographic signals 
were indeed demonstrable over cells unequivocally rec-
ognized as hepatocytes (four cases) and adrenal cortical 
cells (two cases) by their location, relationship to other 
parenchymal cells, rectangular to polygonal shapes, and 
abundant cytoplasm. 
This demonstration of EBV genomes in the hepato-
cytes and adrenals of four children is a novel and very 
significant finding, We believe that the signals observed 
represent true hybridization: histologically normal pediat-
ric liver and adrenals, as well as similar tissues with infil-
trates of acute lymphocytic leukemia, did not show any 
nonspecific deposition of silver grains over epithelial cells 
(n = 12). The mechanism of EBV entry into the liver and 
adrenal cells is a matter for speculation. Virus entry into 
target cells is believed to be critically dependent on the 
expression of a specific EBV/C3d receptor. Initially it 
was believed that the EBV receptor occurs only on B 
cells.25-27 However subsequently receptors have been 
documented on T-cell, null cell, and other hematopoietic 
cell lines, platelets, oropharyngeal epithelium, and hu-
man ectocervix.2B-33 The EBV receptor has not been 
1032 Randhawa et al 
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documented yet on either adrenal cells or on hepato-
cytes. However hepatitis is a common clinical manifesta-
tion of disseminated EBV syndromes occurring in immu-
nosuppressed liver transplant recipients 34 While such 
hepatitis may be largely mediated by lymphocyte-driven 
cytotoxic mechanisms, electron microscopy has docu-
mented the occurrence of viruslike particles within the 
liver celis, in fatal EBV-induced infectious mononucleo-
sis. 35 Our demonstration of EBV genomes within hepato-
cytes in four cases extends this observation. We are not 
aware of any studies that demonstrate the presence, or 
for that matter, the absence of the EBV/C3d receptor on 
hepatocytes. In the absence of such receptors, penetra-
tion of the virus into the liver cells could, perhaps, result 
from emperipolesis, a phenomenon described in hepati-
tis B virus infection.36 Altemately we can speculate that 
the EBV nucleocapsid could acquire an envelope from 
an unrelated epitheliotropic virus, and thus effect entry 
into the liver cells.37 
One final observation afforded by the study was that 
the distribution of EBV in these cases appeared to be 
organ restricted rather than generalized. In five patients 
there were organs free of PTLD, but which had inflamma-
tory mononuclear infiltrates in which EBV genomes could 
not be demonstrated, at least within the limits of detection 
of our in situ hybridization procedure (Table 1). The un-
derlying causes of these inflammatory infiltrates varied 
widely and included bacterial myocarditis with gram-
positive cocci, disseminated cryptococosis/torulopsis, 
mixed bacterial pneumonia, and fibrinous pericarditis. 
Post-transplantation Iymphoproliferative disease infil-
trates in these same patients at other organ sites showed 
the presence of EBV genomes in tissue infiltrates, as well 
as inside the lumen of several small blood vessels. The 
failure of the inflammatory response to recruit intravascu-
lar EBV-positive cells into organs not affected by PTLD 
leads us to speculate that EBV transformation of circulat-
ing lymphocytes perhaps leads to loss of endothelial-
adhesion molecule expression on the cell surface.38 
Such a functional defect would interfere with the tran-
scapillary migration of lymphocytes into sites of inflam-
mation within individual organs. 
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